VIVACITY-MG: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACO-KINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF NIPOCALIMAB ADMINISTERED TO ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

被引：0

作者：

Antozzi, Carlo ^{[1
]}

Guptill, Jeffrey ^{[2
]}

Bril, Vera ^{[3
]}

Gamez, Josep ^{[4
]}

Meuth, Sven G. ^{[5
]}

Blanco, Jose L. M. ^{[6
]}

Nowak, Richard J. ^{[7
]}

Quan, Dianna ^{[8
]}

Sevilla, Teresa ^{[9
]}

Szczudlik, Andrzej ^{[10
]}

Hegarty, Brooke ^{[11
]}

Jouvin, Marie-Helene ^{[11
]}

Jin, Jim ^{[11
]}

Arroyo, Santiago ^{[11
]}

机构：

[1] Fdn Ist Neurol Carlo Besta, Milan, Italy

[2] Duke Univ, Sch Med, Durham, NC USA

[3] Univ Toronto, Div Neurol, Toronto, ON, Canada

[4] Hosp Univ Vall Hebron, Neuromuscular Unit, Barcelona, Spain

[5] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany

[6] Hosp Gen Univ Gregorio Maranon, Serv Neurol, Madrid, Spain

[7] Yale Univ, Sch Med, New Haven, CT USA

[8] Univ Colorado, Sch Med, Aurora, CO USA

[9] Hosp Univ Politecn La Fe, Valencia, Spain

[10] Jagiellonian Univ, Med Coll, Krakow, Poland

[11] Momenta Pharmaceut, Cambridge, MA USA

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2023年 / 41卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-119

引用

页码：498 / 498

页数：1

共 50 条

[1] Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis
Guptill, Jeffrey
Antozzi, Carlo
Bril, Vera
Gamez, Josep
Meuth, Sven G.
Blanco, Jose Luis Munoz
Nowak, Richard J.
Quan, Dianna
Sevilla, Teresa
Szczudlik, Andrzej
Hegarty, Brooke
Jouvin, Marie-Helene
Jin, Jim
Arroyo, Santiago
NEUROLOGY, 2021, 96 (15)
[2] A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PK, AND PD OF NIPOCALIMAB (M281) IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
Guptill, J.
Antozzi, C.
Bril, V.
Gamez, J.
Meuth, S.
Munoz Blanco, J.
Nowak, R.
Quan, D.
Sevilla, T.
Szczudlik, A.
Hegarty, B.
Jouvin, M.
Jin, J.
Arroyo, S.
MUSCLE & NERVE, 2020, 62 : S112 - S113
[3] Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study
Antozzi, Carlo
Vu, Tuan
Ramchandren, Sindhu
Nowak, Richard J.
Farmakidis, Constantine
Bril, Vera
De Bleecker, Jan
Yang, Huan
Minks, Eduard
Park, Jin-Sung
Grudniak, Mariusz
Smilowski, Marek
Sevilla, Teresa
Hoffmann, Sarah
Sivakumar, Kumaraswamy
Suzuki, Yasushi
Youssef, Eriene
Sanga, Panna
Karcher, Keith
Zhu, Yaowei
Sheehan, John J.
Sun, Hong
LANCET NEUROLOGY, 2025, 24 (02): : 105 - 116
[4] EFFICACY AND SAFETY OF NIPOCALIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: TOPLINE RESULTS FROM THE DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 3 VIVACITY-MG3 STUDY
Vu, Tuan
Antozzi, Carlo
Ramchandren, Sindhu
Nowak, Richard J.
Farmakidis, Constantine
Bril, Vera
De Bleecker, Jan
Yang, Huan
Minks, Eduard
Park, Jin-Sung
Grudniak, Mariusz
Smilowski, Marek
Sevilla, Teresa
Hoffmann, Sarah
Sivakumar, Kumaraswamy
Youssef, Eriene
Sanga, Panna
Karcher, Keith
Zhu, Yaowei
Ling, Leona
Sun, Hong
MUSCLE & NERVE, 2024, 70 (03) : 655 - 655
[5] A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF NIPOCALIMAB (M281) IN ADULTS WITH GE
Guptill, Jeffrey
Antozzi, Carlo
Bril, Vera
Gamez, Josep
Meuth, Sven
Munoz Blanco, Jose Luis
Nowak, Richard
Quan, Dianna
Sevilla, Teresa
Szczudlik, Andrzej
Hegarty, Brooke
Jouvin, Marie-Helene
Jin, Jim
Arroyo, Santiago
MUSCLE & NERVE, 2020, 62 : S88 - S88
[6] EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (MYCARING)
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali A.
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Woltering, Franz
Bozorg, Ali
Gayfieva, Maryam
Kaminski, Henry
MUSCLE & NERVE, 2022, 65 : S35 - S35
[7] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 3 STUDY OF INEBILIZUMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS (MINT): TOPLINE EFFICACY AND SAFETY FINDINGS
Nowak, Richard
Utsugisawa, Kimiaki
Benatar, Michael
Ciafaloni, Emma
Leite, M. Isabel
Vissing, John
Tang, Fengming
Wu, Yanping
Rojavin, Mikhail
Rampal, Nishi
Howard, James, Jr.
MUSCLE & NERVE, 2024, 70 (03) : 653 - 654
[8] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY OF SUBCUTANEOUS BATOCLIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Nowak, Richard J.
Benatar, Michael
Breiner, Ari
Isaacman, Daniel J.
Bril, Vera
MUSCLE & NERVE, 2022, 65 : S21 - S21
[9] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF TELITACICEPT IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Vu, Tuan
Cui, Xiaoming
Fang, Jianmin
Zuraw, Qing
MUSCLE & NERVE, 2024, 70 (03) : 612 - 612
[10] A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis
Strijbos, Ellen
Tannemaat, Martijn R.
Alleman, Iris
de Meel, Robert H. P.
Bakker, Jaap A.
van Beek, Ruud
Kroon, Frank P.
Rimmelzwaan, Guus F.
Verschuuren, Jan J. G. M.
VACCINE, 2019, 37 (07) : 919 - 925

← 1 2 3 4 5 →